Cargando…

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide

Chlorthalidone (CTD) may be superior to hydrochlorothiazide (HCTZ) in the reduction of adverse cardiovascular events in hypertensive patients. The mechanism of the potential benefit of CTD could be related to antiplatelet effects. The objective of this study was to determine if CTD or HCTZ have anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bashir, Khalid, Burns, Tammy, Pirruccello, Samuel J., Aurit, Sarah J., Hilleman, Daniel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Adherence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581091/ https://www.ncbi.nlm.nih.gov/pubmed/36067089 http://dx.doi.org/10.1111/jch.14564

Ejemplares similares

Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real‐world data analysis
por: Beall, Reed F., et al.
Publicado: (2022)

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
por: Dineva, Stela, et al.
Publicado: (2019)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
por: Chekka, Lakshmi Manasa S., et al.
Publicado: (2022)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
por: Hripcsak, George, et al.
Publicado: (2020)

Identification of Cardiovascular Patient Groups at Risk for Poor Medication Adherence: A Cluster Analysis
por: Sieben, Angelien, et al.
Publicado: (2021)

Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis
por: Khenhrani, Raja Ram, et al.
Publicado: (2023)

Impact of medication adherence on the efficacy of Baroreflex activation therapy
por: Schäfer, Ann‐Kathrin C., et al.
Publicado: (2022)

Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients
por: Dineva, Stela, et al.
Publicado: (2020)

Factors Associated With Nonadherence to Cardiovascular Medications: A Cross-sectional Study
por: van der Laan, Danielle M., et al.
Publicado: (2019)

Determination of level of self‐reported adherence of antihypertensive drug(s) and its associated factors among patient with hypertension at a tertiary care center
por: Bhusal, Laxman, et al.
Publicado: (2022)

Drug adherence and psychological factors in patients with apparently treatment‐resistant hypertension: Yes but which ones?
por: Georges, Coralie M. G., et al.
Publicado: (2022)

Failure to follow medication changes made at hospital discharge is associated with adverse events in 30 days
por: Weir, Daniala L., et al.
Publicado: (2020)

Clinical impact of medication adherence on 10‐year cardio‐cerebrovascular mortality in newly diagnosed hypertensive patients
por: Kim, Cho‐Long, et al.
Publicado: (2021)

Early adherence to antihypertensive drugs and long‐term cardiovascular mortality in the “real world”
por: Salazar, Martin R.
Publicado: (2021)

Improving adherence with eye medication: a patient-centred approach to prescribing
por: Wiafe, Boateng, et al.
Publicado: (2023)

Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function
por: Edwards, Cedric, et al.
Publicado: (2021)

Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysis
por: Filipova, Elena, et al.
Publicado: (2020)

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Medication adherence and community pharmacy: a review of education, policy and research in England
por: Clifford, Sarah, et al.
Publicado: (2010)

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)

Medication adherence: a review of pharmacy education, research, practice and policy in Finland
por: Bell, J. Simon, et al.
Publicado: (2010)

Adherence: a review of education, research, practice, and policy in the United States
por: Rickles, Nathaniel M., et al.
Publicado: (2010)

Adherence policy, education and practice – an international perspective
por: Marie-Schneider, Paule, et al.
Publicado: (2010)

Adherence: a review of education, research, practice and policy in Switzerland
por: Schneider, Marie P., et al.
Publicado: (2009)

Adherence: a review of education, research, practice and policy in Australia
por: Aslani, Parisa, et al.
Publicado: (2009)

Adherence: a review of education, research, practice and policy in Spain
por: Fikri-Benbrahim, Narjis, et al.
Publicado: (2009)

Adherence to treatment: practice, education and research in Danish community pharmacy
por: Haugbølle, Lotte S., et al.
Publicado: (2009)

Adherence to treatment: what is done in Sweden? Practice, education and research
por: Södergård., Björn
Publicado: (2008)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Patients’ beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia
por: Chiu, K.-C., et al.
Publicado: (2014)

Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial
por: Martins, Vítor Magnus, et al.
Publicado: (2019)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal
por: Rodríguez-Ruiz, Christian, et al.
Publicado: (2022)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Impact of Grapefruit Juice on the Antiplatelet Activity of Loading and Maintenance Doses of Clopidogrel in Healthy Volunteers
por: Campbell, Jennifer A., et al.
Publicado: (2014)

Drug-induced acute myopia following chlorthalidone treatment
por: Mahesh, G, et al.
Publicado: (2007)

Azilsartan/chlorthalidone combination therapy for blood pressure control
por: Cheng, Judy WM
Publicado: (2013)

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
por: Shuster, Jerrica E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3n44hjnabo5a1n3fe50u5smcj6